Research finds increased heart attack risk among antipsychotic users
May 18, 2016
People who take antipsychotic medications may be at increased risk for heart attacks, according to a new study.
Operator agrees to pay $120,000, leave state due to allegedly misleading marketing materials
By
Lois A. Bowers
Jan 08, 2020
The Vermont attorney general accused the company of violating the state’s Consumer Protection Act by misrepresenting to families of prospective residents, via its brochure, website and conversations,...
New law requires central, locked storage of guns at assisted living communities
By
Lois A. Bowers
Oct 21, 2019
California assisted living communities that allow guns on their premises will be required to centrally store the guns, unloaded, in a locked gun safe under a bill signed into law by Gov. Gavin Newsom (D).
Affinity Living tests light’s effects on residents living with dementia
Jun 24, 2019
New studies by Affinity Living Group and the University of North Carolina Chapel Hill aim to use light to reduce the number of falls or amount of agitation in residents living with dementia.
Low scam awareness may predict later dementia diagnosis
By
Lois A. Bowers
Apr 22, 2019
An older adult’s low awareness of scams may be an indicator that he or she may receive a diagnosis of Alzheimer’s disease or mild cognitive impairment in the future, according to the results of a new...
Hospital sends woman with dementia to locked senior living community
By
John O'Connor
Feb 01, 2019
Long Beach, CA-based College Medical Center dumped a woman with dementia outside the locked senior living community where she lived in the middle of the night, a daughter’s negligence complaint alleges.
$625,000 stipend will continue work to alter perceptions of aging, dementia
By
Lois A. Bowers
Oct 05, 2016
Anne Basting’s work to improve older adults’ quality of life and change perceptions related to aging and dementia recently received a big boost in the form of a $625,000 “genius grant”...
Anticholinergic drugs don’t raise dementia risk in those with Parkinson’s
By
Lois A. Bowers
Jan 05, 2016
Concern that anticholinergic drugs could potentially worsen cognition in those with Parkinson’s disease are unfounded, according to new research reported in the Journal of Parkinson’s Disease.
Home Care briefs for Friday, June 18
By
Diane Eastabrook
Jun 18, 2021
Online mental health therapy significantly helped the isolated during pandemic … CMS chief applauds Supreme Court ruling on ACA … Chatbots for dementia patients and caregivers work but need help...
More news for Tuesday, March 1
By
Kimberly Bonvissuto
Mar 01, 2022
NHI, Welltower work toward settlement regarding Holiday Retirement properties … Proclamation lifts some restrictions for Washington state assisted living communities … State drops case against nurse...